In most cancers, it is carcinogenic driver mutations such as activation of K-ras, c-Myc, and phosphatidylinositol-3 (PI3) kinases or loss of phosphatase and tensin homologues and p53 that promote glycolysis, rather than mutations in the inactivated mitochondrial respiratory complex. Here, TP53 is linked to cancer.